Trial Profile
A Randomized Trial of Early Conversion From Calcineurin Inhibitors (CNI) to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Belatacept (Primary) ; Ciclosporin; Tacrolimus
- Indications Delayed graft function; Renal transplant rejection
- Focus Biomarker; Therapeutic Use
- 24 Sep 2014 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
- 24 Sep 2014 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
- 24 Sep 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.